Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
即使市場處於歷史高點，也會在動盪和不確定性時期，許多投資者轉向股息率較高的股票。這些公司通常具有較高的自由現金流量，並用高分紅回報股東。
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Benzinga的讀者可以查看我們的分析師股票評級頁面，查看最新的分析師對他們最喜愛的股票的看法。交易員可以瀏覽Benzinga的廣泛分析師評級數據庫，包括按分析師準確性排序。
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
以下是醫療保健板塊三隻高收益股票最準確的分析師評級。
Pfizer Inc. (NYSE:PFE)
輝瑞公司(NYSE:PFE)
- Dividend Yield: 5.81%
- Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating with a price target of $45 on July 10. This analyst has an accuracy rate of 70%.
- BMO Capital analyst Evan David Seigerman reiterated an Outperform rating and raised the price target from $33 to $36 on May 2. This analyst has an accuracy rate of 70%.
- Recent News: On July 11, Pfizer announced it selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist.
- Benzinga Pro's real-time newsfeed alerted to latest Pfizer's news
- 股息收益率：5.81%
- 7月10日，Cantor Fitzgerald的分析師Louise Chen重申超配評級並給出了45美元的目標價。這位分析師的準確率爲70%。
- 5月2日，BMO Capital的分析師Evan David Seigerman重申跑贏大盤評級，並將目標價從33美元上調至36美元。這位分析師的準確率爲70%。
- 最近消息：7月11日，輝瑞公司宣佈選擇其優先的曲格列酮緩釋劑配方，用於口服胰高血糖素樣多肽-1（GLP-1）受體激動劑danuglipron。
- Benzinga Pro的實時新聞提醒了最新的輝瑞公司新聞。
CVS Health Corporation (NYSE:CVS)
西維斯健康公司（紐約證券交易所股票代碼：CVS）
- Dividend Yield: 4.51%
- Argus Research analyst Chris Graja maintained a Buy rating and cut the price target from $100 to $80 on May 8. This analyst has an accuracy rate of 70%.
- Truist Securities analyst David Macdonald reiterated a Buy rating and lowered the price target from $90 to $66 on May 2. This analyst has an accuracy rate of 71%.
- Recent News: CVS Health said it will report second-quarter financial results on Wednesday, Aug. 7.
- Benzinga Pro's charting tool helped identify the trend in CVS stock.
- 股息收益率：4.51%
- 5月8日，Argus Research的分析師Chris Graja維持買入評級，並將目標價下調至80美元。這位分析師的準確率爲70%。
- 5月2日，Truist Securities的分析師David Macdonald重申買入評級，並將目標價從90美元下調至66美元。這位分析師的準確率爲71%。
- 最近消息：西維斯健康表示，將於8月7日（星期三）公佈第二季度財務業績。
- Benzinga Pro的圖表工具幫助識別了CVS股票的趨勢。
Medtronic plc (NYSE:MDT)
美敦力（MDT）公司（紐交所MDT）
- Dividend Yield: 3.59%
- Wells Fargo analyst Larry Biegelsen maintained an Overweight rating and raised the price target from $102 to $105 on May 24. This analyst has an accuracy rate of 73%.
- Mizuho analyst Anthony Petrone maintained a Buy rating and increased the price target from $95 to $98 on Feb. 21. This analyst has an accuracy rate of 65%.
- Recent News: On June 26, Medtronic announced the resignation of EVP and CFO Karen Parkhill.
- Benzinga Pro's signals feature notified of a potential breakout in Medtronic's shares.
- 股息收益率：3.59%
- 5月24日，富國銀行的分析師Larry Biegelsen維持超配評級，並將目標價從102美元上調至105美元。這位分析師的準確率爲73%。
- 2月21日，瑞穗證券的分析師Anthony Petrone維持買入評級，並將目標價從95美元上調至98美元。這位分析師的準確率爲65%。
- 最近消息：6月26日，美敦力宣佈執行副總裁兼首席財務官Karen Parkhill辭職。
- Benzinga Pro的信號特徵提示了美敦力股票可能出現突破。
Read More:
閱讀更多：
- How To Earn $500 A Month From Bank of America Stock Ahead Of Q2 Earnings
- 如何在美國銀行股份二季度收益發布前每月賺取500美元
譯文內容由第三人軟體翻譯。